Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZBTB20 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TXNL1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EXOSC7 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RAB3A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MAP1B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ZMIZ2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LIMCH1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SEPHS2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MIR4800 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ARFIP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CAT - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TMED10 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EXOC7 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NES - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PRRC2B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ALDH6A1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
AGK - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SP110 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MIR1306 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FHL3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on